title: Selection and adaptation during metastatic cancer progression.
abstract: Cancer is often regarded as a process of asexual evolution driven by genomic and genetic instability. Mutation, selection and adaptation are by convention thought to occur primarily within, and to a lesser degree outside, the primary tumour. However, disseminated cancer cells that remain after 'curative' surgery exhibit extreme genomic heterogeneity before the manifestation of metastasis. This heterogeneity is later reduced by selected clonal expansion, suggesting that the disseminated cells had yet to acquire key traits of fully malignant cells. Abrogation of the cells' progression outside the primary tumour implies new challenges and opportunities for diagnosis and adjuvant therapies.
authors.affiliation: Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany. christoph.klein@ukr.de
authors.forename: Christoph A
authors.initials: CA
authors.lastname: Klein
mesh_terms: D000222:Adaptation, Physiological / Q000235:genetics; D002828:Choristoma; D060965:Clonal Evolution / Q000235:genetics; D018450:Disease Progression; D019143:Evolution, Molecular; D015894:Genome, Human; D006801:Humans; D009154:Mutation / Q000235:genetics; D009362:Neoplasm Metastasis / Q000235:genetics / Q000473:pathology / Q000628:therapy; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology* / Q000628:therapy; D012641:Selection, Genetic / Q000235:genetics; D013997:Time Factors
references.citation: Cell. 2008 Jun 13;133(6):994-1005
references.pmid: 18555776
references.citation: Int J Cancer. 2011 Nov 15;129(10):2522-6
references.pmid: 21207426
references.citation: J Clin Oncol. 2010 Jul 10;28(20):3271-7
references.pmid: 20498394
references.citation: Nature. 2009 Oct 8;461(7265):809-13
references.pmid: 19812674
references.citation: Nature. 2010 Oct 28;467(7319):1109-13
references.pmid: 20981101
references.citation: N Engl J Med. 2009 Sep 3;361(10):947-57
references.pmid: 19692680
references.citation: J Biol Chem. 2010 Mar 19;285(12):8719-32
references.pmid: 20064925
references.citation: Breast Cancer Res Treat. 2012 Feb;131(3):801-8
references.pmid: 21455667
references.citation: Stem Cells. 2010 Jan;28(1):29-35
references.pmid: 19785009
references.citation: Cancer. 2013 Jan 15;119(2):266-76
references.pmid: 22786759
references.citation: J Clin Oncol. 2006 Jan 20;24(3):337-44
references.pmid: 16344321
references.citation: Lancet. 2009 Jan 10;373(9658):125-36
references.pmid: 19070889
references.citation: N Engl J Med. 2012 Feb 23;366(8):707-14
references.pmid: 22356324
references.citation: Cell. 2011 Feb 18;144(4):499-512
references.pmid: 21315436
references.citation: Gastroenterology. 2006 May;130(6):1872-85
references.pmid: 16697750
references.citation: BMC Cancer. 2012 Feb 28;12:78
references.pmid: 22373240
references.citation: Cancer Cell. 2013 May 13;23(5):573-81
references.pmid: 23680145
references.citation: Nat Genet. 1996 Jun;13(2):233-7
references.pmid: 8640234
references.citation: Hum Pathol. 2011 Feb;42(2):244-53
references.pmid: 21238786
references.citation: J Clin Oncol. 2009 Apr 1;27(10):1549-56
references.pmid: 19237635
references.citation: Nature. 2005 Jul 28;436(7050):518-24
references.pmid: 16049480
references.citation: Eur J Cancer. 2006 Apr;42(6):735-44
references.pmid: 16527478
references.citation: Nat Rev Cancer. 2009 Apr;9(4):302-12
references.pmid: 19308069
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6
references.pmid: 10411935
references.citation: Cancer Res. 1975 Mar;35(3):502-5
references.pmid: 1116119
references.citation: Nat Genet. 2006 Apr;38(4):468-73
references.pmid: 16565718
references.citation: Genome Biol. 2011 Oct 19;12(10):R103
references.pmid: 22014273
references.citation: N Engl J Med. 2012 Mar 8;366(10):883-892
references.pmid: 22397650
references.citation: Cancer Metastasis Rev. 2012 Jun;31(1-2):235-46
references.pmid: 22198520
references.citation: Genes Dev. 2002 Mar 15;16(6):693-706
references.pmid: 11914275
references.citation: Nat Rev Cancer. 2008 Feb;8(2):141-7
references.pmid: 18185517
references.citation: N Engl J Med. 2002 Aug 22;347(8):567-75
references.pmid: 12192016
references.citation: Nature. 2010 Apr 15;464(7291):999-1005
references.pmid: 20393555
references.citation: J Clin Invest. 2010 Feb;120(2):636-44
references.pmid: 20101094
references.citation: Lancet. 2002 Aug 31;360(9334):683-9
references.pmid: 12241875
references.citation: Clin Cancer Res. 2012 Feb 1;18(3):688-99
references.pmid: 22173549
references.citation: J Cell Biol. 2013 Mar 18;200(6):689-98
references.pmid: 23509066
references.citation: N Engl J Med. 2005 Aug 25;353(8):793-802
references.pmid: 16120859
references.citation: Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13450-4
references.pmid: 17673550
references.citation: Cancer Cell. 2005 Sep;8(3):227-39
references.pmid: 16169467
references.citation: Br J Cancer. 1997;76(6):765-9
references.pmid: 9310243
references.citation: Int J Cancer. 2010 Feb 1;126(3):589-98
references.pmid: 19795462
references.citation: Cancer Cell. 2008 Jan;13(1):58-68
references.pmid: 18167340
references.citation: Cell. 2011 Oct 14;147(2):275-92
references.pmid: 22000009
references.citation: Int J Cancer. 2008 Nov 1;123(9):1991-2006
references.pmid: 18712708
references.citation: J Pathol. 2001 Nov;195(4):415-21
references.pmid: 11745672
references.citation: Histopathology. 2013 Feb;62(3):367-86
references.pmid: 23339363
references.citation: Clin Cancer Res. 2008 Jan 15;14(2):370-8
references.pmid: 18223211
references.citation: Cancer Cell. 2008 May;13(5):441-53
references.pmid: 18455127
references.citation: Nat Rev Cancer. 2009 Feb;9(2):143; author reply 143
references.pmid: 19132011
references.citation: Br J Cancer. 1947 Dec;1(4):379-82
references.pmid: 18906315
references.citation: J Clin Pathol. 2009 Jun;62(6):516-8
references.pmid: 19126563
references.citation: Nature. 2005 Dec 8;438(7069):820-7
references.pmid: 16341007
references.citation: Cell Cycle. 2006 Aug;5(16):1788-98
references.pmid: 16929175
references.citation: Cell. 2011 Jan 7;144(1):27-40
references.pmid: 21215367
references.citation: Curr Opin Genet Dev. 2011 Feb;21(1):42-9
references.pmid: 21145726
references.citation: Nat Rev Cancer. 2008 Oct;8(10):755-68
references.pmid: 18784658
references.citation: Nat Med. 2013 Mar;19(3):274-5
references.pmid: 23467237
references.citation: Nature. 2012 May 30;485(7400):S58-9
references.pmid: 22648501
references.citation: Hum Reprod. 2009 Jan;24(1):63-70
references.pmid: 18824471
references.citation: Science. 2009 Jun 26;324(5935):1679-82
references.pmid: 19556501
references.citation: Hybridoma. 1986 Jul;5 Suppl 1:S29-37
references.pmid: 2427436
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7737-42
references.pmid: 12808139
references.citation: Science. 1976 Oct 1;194(4260):23-8
references.pmid: 959840
references.citation: Nat Rev Cancer. 2009 Apr;9(4):274-84
references.pmid: 19308067
references.citation: Eur J Cancer. 2003 Aug;39(12):1794-806
references.pmid: 12888376
references.citation: Cancer Res. 2013 May 15;73(10):2965-75
references.pmid: 23471846
references.citation: N Engl J Med. 1988 Sep 1;319(9):525-32
references.pmid: 2841597
references.citation: Theory Biosci. 2009 Mar;128(1):43-51
references.pmid: 19224263
references.citation: J Pathol. 2013 Mar;229(4):515-24
references.pmid: 22996961
references.citation: Cancer Metastasis Rev. 2010 Dec;29(4):737-50
references.pmid: 20878451
references.citation: Cell. 1994 Oct 21;79(2):315-28
references.pmid: 7525077
references.citation: Cancer Genet Cytogenet. 2002 Jul 1;136(1):66-72
references.pmid: 12165455
references.citation: Nature. 2009 Jun 18;459(7249):1005-9
references.pmid: 19421193
references.citation: Bioinformatics. 2001 Dec;17(12):1228-9
references.pmid: 11751233
references.citation: Cancer Cell. 2003 Jun;3(6):537-49
references.pmid: 12842083
references.citation: Nat Med. 2012 Jun;18(6):883-91
references.pmid: 22635005
references.citation: Proc Natl Acad Sci U S A. 1987 Dec;84(23):8672-6
references.pmid: 2446326
references.citation: Cancer Res. 2009 Jul 1;69(13):5285-8
references.pmid: 19549904
references.citation: Breast Cancer Res. 2008;10(3):R41
references.pmid: 18466608
references.citation: JAMA. 2012 Apr 4;307(13):1383-93
references.pmid: 22474202
references.citation: Cell. 1982 Nov;31(1):11-24
references.pmid: 6186379
references.citation: Science. 1968 Nov 29;162(3857):1024-6
references.pmid: 4301647
references.citation: Cancer Res. 2011 Nov 15;71(22):7113-24
references.pmid: 22084446
references.citation: N Engl J Med. 2001 Mar 15;344(11):783-92
references.pmid: 11248153
references.citation: J Clin Invest. 2011 Apr;121(4):1298-312
references.pmid: 21436587
references.citation: Am J Pathol. 1989 Jul;135(1):63-71
references.pmid: 2774059
references.citation: Eur J Cancer. 1999 Sep;35(9):1320-5
references.pmid: 10658521
references.citation: Nat Cell Biol. 2013 Jul;15(7):807-17
references.pmid: 23728425
references.citation: Adv Cancer Res. 2011;112:217-53
references.pmid: 21925306
references.citation: Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10356-61
references.pmid: 11526241
references.citation: J Clin Oncol. 2010 Nov 1;28(31):4697-705
references.pmid: 20921465
references.citation: Cancer Res. 2013 Jan 1;73(1):30-40
references.pmid: 23135909
references.citation: Nat Cell Biol. 2008 Nov;10(11):1349-55
references.pmid: 18820689
references.citation: Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20780-5
references.pmid: 21078999
references.citation: Adv Cancer Res. 2011;112:127-49
references.pmid: 21925303
references.citation: Nature. 2010 Oct 28;467(7319):1114-7
references.pmid: 20981102
references.citation: Cell. 2013 Jan 31;152(3):394-405
references.pmid: 23374337
references.citation: Nature. 2012 Jan 18;481(7381):306-13
references.pmid: 22258609
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6215-21
references.pmid: 18434545
references.citation: Nature. 1975 May 15;255(5505):197-200
references.pmid: 1143315